Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis

Costello, C M; O'Connor, C M; Finlay, G A; Shiels, P; FitzGerald, M X; Hayes, J P
June 1996
Thorax;Jun1996, Vol. 51 Issue 6, p619
Academic Journal
No abstract available.


Related Articles

  • Pulmonary.  // Africa Health;Jul2011, Vol. 33 Issue 5, p59 

    The article reports on a 5-year follow-up for acute respiratory distress syndrome (ARDS), the large part played by nebulised recombinant human DNase in adults with cystic fibrosis, and the use of inhaled long-acting bronchodilators for patients with severe chronic obstructive pulmonary disease.

  • In Vitro Inhibition of Neutrophil Elastase Activity by Inhaled Anti-Pseudomonas Antibiotics Used in Cystic Fibrosis Patients. Hector, Andreas; Kappler, Matthias; Griese, Matthias // Mediators of Inflammation;2010, Vol. 2010, p1 

    Background. Inhaled antibiotics are commonly used in the treatment of cystic fibrosis lung disease. A previous study suggested neutrophil elastase activation by colistin in vitro. Here, we investigated direct effects of the commonly used antibiotics colistin and tobramycin on neutrophil elastase...

  • Prolastin aerosol therapy and sputum taurine in cystic fibrois. Cantin, AndrĂ© M.; Berthiaume, Yves; Cloutier, Diane; Martel, Marc // Clinical & Investigative Medicine;Aug2006, Vol. 29 Issue 4, p201 

    The article discusses the effects of Prolastin aerosol therapy on airway inflammation in cystic fibrosis. Prolastin is a therapeutic preparation of alpha-1 proteinase inhibitor, a neutrophil elastase inhibitor. It also presents a conclusion that aerosol therapy with Prolastin in patients with...

  • Cystic fibrosis in children.  // Thorax;Dec2007 Supp, Vol. 62, pA102 

    The article presents abstracts on medical topics which include the effectiveness of inhibitor DX-890 in preventing IL-8 release stimulated by neutrophil elastase, the management of cystic fibrosis cases related to diabetes in Great Britain, and the regional improvements in pediatric cystic...

  • Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis. Suri, R.; Grieve, R.; Normond, C.; Metcalfe, C.; Thompson, S.; Wallis, C.; Bush, A. // Thorax;Oct2002, Vol. 57 Issue 10, p841 

    Background: Daily recombinant human deoxyribonuclease (rhDNase) is an established but expensive treatment in cystic fibrosis (CF). An alternative lower cost therapy is hypertonic saline (HS), which has been shown to improve lung function in short term studies. This study compares the costs and...

  • Effect of Recombinant Human DNase on a1-Proteinase Inhibitor Function: An Experimental Approach to the Combined Clinical Use of rhDNase and a1-PI in CF Patients. Hansen, G.; Hoffjan, S.; Mosler, K.; Schuster, A. // Lung;2001, Vol. 179 Issue 3, p185 

    Chronic inflammation in cystic fibrosis (CF) airways leads to high concentrations of deoxyribonucleic acid (DNA) and neutrophil elastase (NE). Both play a major role in CF lung pathophysiology and are aims of new therapeutic approaches: rhDNase degrades highly viscosic DNA and a1-proteinase...

  • Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial. C Minasian // Thorax;Jan2010, Vol. 65 Issue 1, p51 

    BACKGROUND: Osmotic agents, such as inhaled dry powder mannitol, may increase mucociliary clearance by rehydrating the airway surface liquid and thus act as disease-modifying treatments in cystic fibrosis (CF). This is the first therapeutic trial of inhaled mannitol in children with CF; it was...

  • The Use of Human Deoxyribonuclease (rhDNase) in the Management of Cystic Fibrosis. Suri, Ranjan // BioDrugs;2005, Vol. 19 Issue 3, p135 

    In patients with cystic fibrosis (CF), the poor clearance of airway secretions promotes recurrent cycles of pulmonary infection and inflammation. In recent years, novel drugs have been developed to alter the properties of the secretions in an attempt to aid chest physiotherapy in improving...

  • Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. Vandivier, R. William; Fadok, Valerie A.; Hoffmann, Peter R.; Bratton, Donna L.; Penvari, Churee; Brown, Kevin K.; Brain, Joseph D.; Accurso, Frank J.; Henson, Peter M. // Journal of Clinical Investigation;3/1/2002, Vol. 109 Issue 5, p661 

    Cystic fibrosis is characterized by an early and sustained influx of inflammatory cells into the airways and by release of proteases. Resolution of inflammation is normally associated with the orderly removal of dying apoptotic inflammatory cells through cell recognition receptors, such as the...

  • Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis. Byrne N M; Keavey P M; Perry J D; Gould F K; Spencer D A // Archives of Disease in Childhood;Aug2003, Vol. 88 Issue 8, p715 

    AIM: To examine the effectiveness of delivery of nebulised colistin by the HaloLite nebuliser compared to the Pari LC Plus in patients with cystic fibrosis. METHODS: Randomised crossover trial of 15 patients aged >6 years. Inhalation of one mega unit of colistin in 3 ml diluent, labelled with...


Read the Article


Sign out of this library

Other Topics